Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Jeyakumar

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Ejhaem|January 30, 2026
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active TransformationBenjamin J Lee, Shawn P Griffin, Deepa Jeyakumar, et al.
Case Reports in Hematology|December 30, 2024
Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)Anthony Crymes, Mark G Evans, Deepa Jeyakumar, et al.
Annals of Hematology|October 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experienceBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
American Journal of Hematology|February 16, 2023
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemiaBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Blood Neoplasia|June 24, 2025
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategyElizabeth A Brem, Kevin Shieh, Dennis Juarez, et al.
Cancer Genetics|August 29, 2025
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion)Ying Zhang, Jack Reid, Deepa Jeyakumar, et al.
Haematologica|July 11, 2024
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantationPongthep Vittayawacharin, Benjamin J Lee, Shawn Griffin, et al.
American Journal of Hematology|September 3, 2022
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switchBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
American Journal of Hematology|January 8, 2025
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell TransplantationPiyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Ejhaem|January 30, 2026
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active TransformationBenjamin J Lee, Shawn P Griffin, Deepa Jeyakumar, et al.
Case Reports in Hematology|December 30, 2024
Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)Anthony Crymes, Mark G Evans, Deepa Jeyakumar, et al.
Annals of Hematology|October 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experienceBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
American Journal of Hematology|February 16, 2023
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemiaBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Blood Neoplasia|June 24, 2025
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategyElizabeth A Brem, Kevin Shieh, Dennis Juarez, et al.
Cancer Genetics|August 29, 2025
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion)Ying Zhang, Jack Reid, Deepa Jeyakumar, et al.
Haematologica|July 11, 2024
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantationPongthep Vittayawacharin, Benjamin J Lee, Shawn Griffin, et al.
American Journal of Hematology|September 3, 2022
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switchBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
American Journal of Hematology|January 8, 2025
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell TransplantationPiyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, et al.
Pageof 5